EXAS
Income statement / Annual
Last year (2023), Exact Sciences Corporation's total revenue was $2.50 B,
an increase of 19.93% from the previous year.
In 2023, Exact Sciences Corporation's net income was -$204.15 M.
See Exact Sciences Corporation’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$2.50 B
|
$2.08 B
|
$1.77 B
|
$1.49 B
|
$876.29 M
|
$454.46 M
|
$265.99 M
|
$99.38 M
|
$39.44 M
|
$1.80 M
|
| Cost of Revenue |
$654.25 M |
$574.39 M |
$458.76 M |
$354.32 M |
$216.72 M |
$117.98 M |
$79.20 M |
$45.20 M |
$24.50 M |
$4.33 M |
| Gross Profit |
$1.85 B |
$1.51 B |
$1.31 B |
$1.14 B |
$659.58 M |
$336.48 M |
$186.79 M |
$54.18 M |
$14.94 M |
-$2.53 M |
| Gross Profit Ratio |
0.74 |
0.72 |
0.74 |
0.76 |
0.75 |
0.74 |
0.7 |
0.55 |
0.38 |
-1.41 |
| Research and Development
Expenses |
$425.88 M
|
$393.42 M
|
$385.65 M
|
$554.05 M
|
$139.69 M
|
$68.21 M
|
$42.14 M
|
$33.47 M
|
$33.91 M
|
$28.67 M
|
| General & Administrative
Expenses |
$1.42 B
|
$737.30 M
|
$801.26 M
|
$481.72 M
|
$352.45 M
|
$178.29 M
|
$109.04 M
|
$76.90 M
|
$57.95 M
|
$30.44 M
|
| Selling & Marketing
Expenses |
$203.90 M
|
$846.01 M
|
$861.89 M
|
$589.92 M
|
$385.18 M
|
$249.45 M
|
$153.92 M
|
$112.83 M
|
$82.14 M
|
$38.91 M
|
| Selling, General &
Administrative Expenses |
$1.62 B
|
$1.58 B
|
$1.66 B
|
$1.07 B
|
$737.63 M
|
$427.74 M
|
$262.96 M
|
$189.72 M
|
$140.09 M
|
$69.34 M
|
| Other Expenses |
$14.35 M |
$110.69 M |
$95.00 M |
$69.73 M |
$16.04 M |
$0.00 |
$107.60 M |
$0.00 |
$4.10 M |
$1.60 M |
| Operating Expenses |
$2.06 B |
$2.09 B |
$2.14 B |
$1.70 B |
$893.36 M |
$495.95 M |
$305.10 M |
$223.20 M |
$174.00 M |
$98.01 M |
| Cost And Expenses |
$2.71 B |
$2.66 B |
$2.60 B |
$2.05 B |
$1.11 B |
$613.93 M |
$384.30 M |
$268.39 M |
$198.51 M |
$102.34 M |
| Interest Income |
-$5.35 M |
$19.63 M |
$1.79 M |
$6.57 M |
$23.77 M |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Interest Expense |
$24.42 M |
$19.63 M |
$18.61 M |
$95.98 M |
$61.60 M |
$36.79 M |
$206,000.00 |
$213,000.00 |
$6,000.00 |
$51,000.00 |
| Depreciation &
Amortization |
$206.61 M
|
$226.20 M
|
$206.17 M
|
$179.08 M
|
$55.67 M
|
$23.08 M
|
$15.56 M
|
$11.51 M
|
$7.75 M
|
$3.71 M
|
| EBITDA |
$41.88 M
|
-$386.74 M
|
-$617.73 M
|
-$632.86 M
|
-$217.75 M
|
-$115.18 M
|
-$98.82 M
|
-$155.49 M
|
-$150.05 M
|
-$96.29 M
|
| EBITDA Ratio |
0.02 |
-0.23 |
-0.42 |
-0.31 |
-0.25 |
-0.35 |
-0.44 |
-1.7 |
-4.03 |
-55.92 |
| Operating Income Ratio
|
-0.09
|
-0.28
|
-0.47
|
-0.37
|
-0.27
|
-0.35
|
-0.44
|
-1.7
|
-4.03
|
-55.92
|
| Total Other
Income/Expenses Net |
$13.27 M
|
-$39.06 M
|
$13.17 M
|
-$61.37 M
|
-$35.07 M
|
-$15.59 M
|
$3.73 M
|
$1.81 M
|
$1.27 M
|
$491,000.00
|
| Income Before Tax |
-$201.75 M |
-$632.57 M |
-$842.51 M |
-$857.11 M |
-$268.85 M |
-$175.06 M |
-$114.58 M |
-$167.21 M |
-$157.80 M |
-$100.05 M |
| Income Before Tax Ratio
|
-0.08
|
-0.3
|
-0.48
|
-0.57
|
-0.31
|
-0.39
|
-0.43
|
-1.68
|
-4
|
-55.64
|
| Income Tax Expense |
$2.40 M |
-$9.06 M |
-$246.88 M |
-$8.57 M |
-$184.86 M |
$92,000.00 |
-$187,000.00 |
-$11.30 M |
-$7.74 M |
-$3.66 M |
| Net Income |
-$204.15 M |
-$623.51 M |
-$595.63 M |
-$848.53 M |
-$83.99 M |
-$175.15 M |
-$114.40 M |
-$167.21 M |
-$157.80 M |
-$100.05 M |
| Net Income Ratio |
-0.08 |
-0.3 |
-0.34 |
-0.57 |
-0.1 |
-0.39 |
-0.43 |
-1.68 |
-4 |
-55.64 |
| EPS |
-1.13 |
-3.54 |
-3.48 |
-5.61 |
-0.64 |
-1.43 |
-0.99 |
-1.63 |
-1.71 |
-1.25 |
| EPS Diluted |
-1.13 |
-3.54 |
-3.48 |
-5.61 |
-0.64 |
-1.43 |
-0.99 |
-1.63 |
-1.71 |
-1.25 |
| Weighted Average Shares
Out |
$180.14 M
|
$176.35 M
|
$171.35 M
|
$151.14 M
|
$131.26 M
|
$122.21 M
|
$115.68 M
|
$102.34 M
|
$92.14 M
|
$80.23 M
|
| Weighted Average Shares
Out Diluted |
$180.14 M
|
$176.35 M
|
$171.35 M
|
$151.14 M
|
$131.26 M
|
$122.21 M
|
$115.68 M
|
$102.34 M
|
$92.14 M
|
$80.23 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
